![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EMD Serono Wins FDA Nod for Redesigned Pen Injector
EMD Serono Wins FDA Nod for Redesigned Pen Injector
EMD Serono won the FDA’s approval for a redesigned version of its Gonal-f RFF Redi-ject pen injector.
First approved in 2013, the device is designed to inject follitropin alfra to induce ovulation and pregnancy in oligo-anovulatory women.
The redesigned pen was evaluated in a simulated-use study involving 86 women with infertility and 30 fertility nurses.
Upcoming Events
-
21Oct